Cancer Research KI
Cancer Research KI is an overarching umbrella organisation of cancer research at Karolinska Institutet, that includes more than 350 research groups. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the goal to aid generating new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
The Cancer Research KI missions
Educating
News
Cancer Research KI PI Retreat 2025 Recap
During February 17th and 18th, 80 principal investigators from 13 departments at KI, both from the Solna and Flemingsberg campuses, participated in the Cancer Research KI PI Retreat in Djurönäset. The participating researchers covered pre-clinical, translational, clinical, and epidemiological research areas. The event featured research presentations, elevator pitches, and, for the first time this year, a session on Personalized Cancer Medicine and Clinical Trials, followed by a panel discussion. Additionally, a Fast-Track Collaboration Challenge was held to foster new collaborations among the participating PIs.
Rolf Kiessling awarded for his groundbreaking discovery of natural killer (NK) cells
Prestigious Göran Gustafsson Prize to Laura Baranello
Laura Baranello, principal researcher at the Department of Cell and Molecular Biology at Karolinska Institutet, receives the Göran Gustafsson Prize in molecular biology. The goal of her research is to find a new strategy for gentler cancer treatments. The idea is to improve both survival and quality of life for patients in the future.
"The biggest challenge today with chemotherapy is that the drugs cannot distinguish between cancer cells and fast-growing healthy cells. This means that doctors sometimes hesitate to start treatment because the patient suffers from so many side effects. Our goal is to achieve a greater understanding of the molecular mechanism of the topoisomerases in cancer cells using a combination of genomics and molecular biology approaches".
En dag för cancerforskning 2024
Watch the recordings of En dag för cancerforskning 2024 here.
2024 Blue Sky grant recipients
Congratulations to the Blue Sky grant recipients of 2024:
Claudia Kutter, Erdinc Sezgin, Joel Rurik, Kimmo Kartasalo, Lisa Westerberg, Niklas Björkström, Oliver Mortusewicz, Qiang Pan Hammarström, Roland Fiskesund, and Tom Erkers
Events, Seminars and Workshops
Photo: n/aRadiotherapy Workshop with the National Institute of Oncology Budapest
The second radiotherapy workshop in Stockholm within the framework of the "twinning agreement" between KI and NIO will take place 12-13 May 2025. The workshop will cover radiotherapy (RT) related research ongoing at Karolinska University Hospital, KI and NIO. It will cover several topics such as brachytherapy, SBRT, clinical RT trials and preclinical RT research.
Date: 12-13 May 2025
Information about the program and registration link can be found here.
Photo: pixabayIndustry-Academia Collaborations Seminar Series 13 May 2025: Intellectual Property
Cancer Research KI, External Engagement office (EEO) and KI Innovations invite you to a joint seminar on the topic of "Intellectual Property (IPR)", where we will explore the fundamentals of IPR and its importance in both academia and industry. The seminar is open to everyone, however, it is especially tailored for PhD Students and Postdoctoral Researchers looking to navigate the basics of IPR in Sweden.
Date and venue: 13 May 2025, Ragnar Granit, Biomedicum
Time: 15:00 (programme starts at 15:30)
Speakers: Andreas Lundquist and Fernando Farieta (EEO). Check the full programme for the event.
Registration: Please, register here for the seminar.
Photo: n/a7th Cancer Swedish Research Meeting in Malmö
Register for the up-coming Swedish Cancer Research Meeting 22-23 May 2025 in Malmö!
The meeting is open to all clinical, preclinical researchers and others with an interest in cancer research from the organizing universities.
The four keynote speakers are Douglas Hanahan, Jana de Boniface, Anna Blom, and Julian Downward. The meeting hosts plenary sessions on the themes: Immunotherapy, Prevention and Biomarker Implementation.
Abstract submission deadline: The deadline for abstract submission is 14th March 2025.
Venue: Clarion Hotel & Congress Malmö Live
Host: Lund University Cancer Centre
Photo: N/AQ&A drop-in session with Cancer Research Horizons, 2 September 2025
The next Q&A drop-in session with Cancer Research Horizons will be held on 2 September, 12:30 - 13:30h, online.
During this session, you will get the chance to ask any questions on the grants or other opportunities to work with Cancer Research Horizons.
No registration is needed, just follow the link to join the meeting
Photo: N/ACancer Research KI retreat at Djurönäset 22-23 September 2025
The XXIInd Cancer Research KI Retreat will take place on September 22-23, 2025 at Djurönäset in the Stockholm archipelago, gathering Cancer Researchers from Karolinska Institutet and University Hospital for an annual joint scientific meeting.
The retreat is currently fully booked.
However, you can still sign up for the waiting list here! We encourage you to register for the chance to get a spot in the most popular CRKI activity.
Photo: n/aCCE Summer School in Translational Cancer Research 5 -10 October 2025
We are pleased to announce that applications are now being accepted for the Cancer Core Europe (CCE) Summer School in Translational Cancer Research, taking place in beautiful Algarve, Portugal from 5 – 10 October 2025.
To apply for the upcoming CCE Summer School, please visit https://www.cancercoreeurope.eu/summerschool/ and submit your application along with a scientific abstract. The deadline for applications is Friday, May 23rd, 2025. Successful applicants will be notified at the end of June.
More information and preliminary programme can be found here.
Grant Announcements
Photo: Getty ImagesTherapeutic Catalyst Grant
Cancer Research UK Therapeutic Catalyst Awards were launched in late 2021 and have been a great success. The scheme operates as a collaborative venture between research scientists and drug discoverers within Cancer Research Horizons to accelerate the translation of novel ideas for therapeutic discovery. Awards can be up to £250,000 to support a 12–18-month proposal. There are 3 rounds of applications per year held in February, June and October.
Next expression of interest deadline: 6 June 2025.